GBP1 binds to proto-oncogene serine/threonine-protein kinase pim-1 (PIM1) and causes paclitaxel resistance in ovarian cancer [47], implying that PIM1 might interact with GBP5 for drug resistance in OSCC. Here, PIM1 is linked to ovarian cancer.